As financing costs surge and interest rates rise, early-stage life sciences businesses must adapt. Discover the key insights in our RSM US Middle Market Business Index special report.
As financing costs surge and interest rates rise, early-stage life sciences businesses must adapt. Discover the key insights in our RSM US Middle Market Business Index special report.